Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > I heard nothing to write home to mother about

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jan 04, 2023 5:03pm

166 Views

Post# 35203692

RE:I heard nothing to write home to mother about

rjc7 wrote: I think we'll be trading in the low .40 for the next six months or so.

While the first half may be slow based on what the CEO said think about how explosive the growth may be in the second half of the year to get to potentially near $30 million in revenue for the year. Think of the run-rate by the end of the year. Then add a Kinlytic deal expected this year.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property